Clinical Trials Sponsored by Vanderbilt-Ingram Cancer Center

Total 1403 results

Vanderbilt-Ingram Cancer Center
National Institutes of Health (NIH)

Active, not recruiting

Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents

Advanced Cancer | Relapsed Cancer | Refractory Cancer

United States
Vanderbilt-Ingram Cancer Center
Human Animal Bond Research Institute

Completed

Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their Parents

Advanced Cancer | Relapsed Cancer | Refractory Cancer

United States
Elizabeth Davis
Bristol-Myers Squibb

Terminated

Nivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression

Metastatic Melanoma | Advanced Melanoma | Metastatic Melanoma Stratified by MHC-II Expression

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); National Comprehensive Cancer Network

Terminated

Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer

Non-Small Cell Lung Carcinoma

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); National Comprehensive Cancer Network

Completed

Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer

Pancreatic Cancer | Periampullary Adenocarcinoma

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); Puma Biotechnology, Inc.

Not yet recruiting

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Invasive Breast Lobular Carcinoma | Anatomic Stage I Breast Cancer | Anatomic Stage II Breast Cancer | Anatomic Stage III Breast Cancer

United States
Vanderbilt-Ingram Cancer Center
Bristol-Myers Squibb; National Cancer Institute (NCI)

Terminated

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma

Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Central Nervous System Lymphoma | Recurrent Central Nervous System Lymphoma

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); Calithera Biosciences, Inc

Active, not recruiting

Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer

Metastatic Colorectal Cancer | Colorectal Cancer | RAS Wild Type Colorectal Cancer | Refractory Colorectal Cancer

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); Cancer Prevention Pharmaceuticals, Inc.

Active, not recruiting

Chemoprevention of Gastric Carcinogenesis

Gastric Cancer | Gastric Intestinal Metaplasia

Honduras, Puerto Rico
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); National Comprehensive Cancer Network

Completed

Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations

Recurrent Melanoma | Stage IV Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); National Comprehensive Cancer Network

Terminated

Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery

Recurrent Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma (Locally Advanced) | Stage IIC Melanoma (Locally Advanced) | Stage IV Melanoma (Limited, Resectable)

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); Karyopharm Therapeutics Inc

Not yet recruiting

Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Relapsed Myelodysplastic Syndrome

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); Varian Medical Systems

Suspended

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Stage III Lung Cancer

United States
Sanjay Mohan
AbbVie; Karyopharm Therapeutics Inc

Active, not recruiting

Venetoclax and Selinexor in Treating Patients With Relapsed or Refractory High Risk Hematologic Malignancies

Acute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell Lymphoma

United States
Vanderbilt-Ingram Cancer Center
Astex Pharmaceuticals, Inc.; Forma Therapeutics, Inc.

Withdrawn

ASTX727 and FT-2102 in Treating IDH1-Mutated Recurrent/Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia

Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome
Vanderbilt-Ingram Cancer Center
Bristol-Myers Squibb; Xcovery Holdings, Inc.

Active, not recruiting

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

Thymic Carcinoma | Non-small Cell Lung Cancer | Small-Cell Lung Cancer | Refractory Thoracic Tumors

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); University of South Florida

Recruiting

Improving Care After Inherited Cancer Testing (IMPACT)

Breast Cancer | Colorectal Cancer | Prostate Cancer | Endometrial Cancer | Inherited Cancer Syndrome

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Comprehensive Cancer Network; Vanderbilt-Ingram Cancer Center

Terminated

A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.

Squamous Cell Carcinoma of the Head and Neck

United States
California Pacific Medical Center Research Institute
Tesaro, Inc.; Vanderbilt-Ingram Cancer Center; Huntsman Cancer Institute

Recruiting

Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation

Metastatic Melanoma

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors

Head Neck Cancer

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

Effect of Epidermal Growth Factor Receptor Inhibitors on Magnesium Homeostasis in Patients With Cancer

Solid Tumor
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); Vanderbilt Office of Clinical and Translational...

Terminated

Home-Based Lymphedema Care Program (HBLCP) in Improving Lymphedema Self-Care in Head and Neck Cancer Survivors

Head and Neck Cancer | Lymphedema

United States
Sanjay Mohan
National Comprehensive Cancer Network; Taiho Oncology, Inc.

Recruiting

Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant

Recurrent Acute Myeloid Leukemia

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Active, not recruiting

Metabolism Informed Smoking Treatment: The MIST RCT

Smoking

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Lymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms

United States
Sonya Reid
Susan G. Komen Breast Cancer Foundation; Agendia

Recruiting

Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort (INSIGHT)

Metastatic Breast Cancer | Invasive Mammary Carcinoma

United States
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center; Northwestern University; Dana-Farber Cancer Institute and other collaborators

Completed

Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer

Bronchioloalveolar Cell Variant of Non-small Cell Lung Cancer

United States
Michael Savona
Incyte Corporation; Astex Pharmaceuticals, Inc.; Theradex

Recruiting

Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO) (ABNL-MARRO)

MDS/MPN

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); Genentech, Inc.; Translational Breast Cancer... and other collaborators

Terminated

Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer

Stage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast Carcinoma

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); National Institute of Dental and Craniofacial...

Completed

Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients

Fibrosis | Lymphedema | Oropharyngeal Cancer | Oral Cavity Cancer

United States
Joseph Paul Eder
Dana-Farber Cancer Institute; The Cleveland Clinic; Vanderbilt-Ingram Cancer...

Terminated

OLAParib COmbinations (OLAPCO)

Cancer

United States
Vanderbilt-Ingram Cancer Center
National Institute of Nursing Research (NINR); Palliative Care Research Cooperative...

Completed

PCRC-Supported Legacy Intervention in Pediatric Palliative Care

Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | Care Giver

United States
Vanderbilt University
National Cancer Institute (NCI)

Completed

Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer

Gastric Cancer | Precancerous Condition

United States
Vanderbilt University
National Cancer Institute (NCI)

Completed

Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Nonmalignant Neoplasm | Lymphoproliferative Disorder | Myelodysplastic/Myeloproliferative Neoplasms | Methemoglobinemia

United States
Vanderbilt University
National Cancer Institute (NCI)

Active, not recruiting

Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing Colonoscopy

Colorectal Cancer | Precancerous Condition

United States
Vanderbilt University
National Cancer Institute (NCI)

Completed

Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention

Colorectal Adenomatous Polyps

United States
Vanderbilt University
National Cancer Institute (NCI)

Completed

Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab (PACE in BC)

Breast Cancer | Cardiac Toxicity | Cardiovascular Complications

United States
Vanderbilt University
National Cancer Institute (NCI)

Terminated

Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Memorial Sloan Kettering Cancer Center
Vanderbilt University

Active, not recruiting

Study of the Effects of Pre-surgical Aerobic Exercise on Patients With Solid Tumors

Solid Tumors | Preoperative Aerobic Training

United States
Vanderbilt University Medical Center
Vanderbilt Kennedy Center

Recruiting

Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition

Alzheimer Disease | Down Syndrome | Down Syndrome, Partial Trisomy 21

United States
Vanderbilt University Medical Center
Vanderbilt Kennedy Center

Recruiting

Use of MRI and cTBS for Catatonia in Autism

Autism Spectrum Disorder | Catatonia

United States
Vanderbilt University Medical Center
National Cancer Institute (NCI); Meharry-Vanderbilt Alliance

Completed

Increasing Minority Participation in Clinical Trials

Clinical Trial

United States
Vanderbilt University Medical Center
National Cancer Institute (NCI)

Recruiting

Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

Head and Neck Cancer

United States
Vanderbilt University Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Family History and Cancer Risk Study (FOREST)

Cancer-related Problem/Condition | Family Characteristics

United States
Vanderbilt University Medical Center
National Cancer Institute (NCI)

Completed

Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission

Leukemia | Fatigue | Long-term Effects Secondary to Cancer Therapy in Children

United States
Vanderbilt University Medical Center
National Cancer Institute (NCI)

Completed

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

Lung Cancer

United States
Vanderbilt University Medical Center
National Cancer Institute (NCI)

Completed

Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer

Head and Neck Cancer

United States
Vanderbilt University Medical Center
National Cancer Institute (NCI)

Completed

DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx

Head and Neck Cancer

United States
Vanderbilt University Medical Center
National Cancer Institute (NCI)

Recruiting

Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients

Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Precancerous Condition

United States
Vanderbilt University Medical Center
National Cancer Institute (NCI)

Completed

Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer

Colorectal Cancer | Precancerous Condition | Hereditary Non-polyposis Colon Cancer

United States

Clinical Trials Sponsored by Vanderbilt-Ingram Cancer Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations